广州科锐特生物科技

Guangzhou Create Biotechnology is a clinical-stage biotechnology company focused on the development of next-generation immune cell therapies for cancer. The company leverages its proprietary high-throughput screening and optimization platforms to design CAR-T, TCR-T, and TIL products with enhanced efficacy and safety profiles. Create Biotech's pipeline includes candidates targeting hematological malignancies and challenging solid tumors, with several programs in clinical development. Beyond drug discovery, the company offers integrated CRO and CDMO services, utilizing its GMP-certified facilities to accelerate the translation of cell and gene therapies.